Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|April 20, 2019
Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengersZahra Dehghani, Mahsima Khoshneviszadeh, Mehdi Khoshneviszadeh, et al.Journal of Pharmaceutical Analysis|January 1, 2020
Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samplesForough Karami, Sara Ranjbar, Younes Ghasemi, et al.Molecular Diversity|November 4, 2018
5-Oxo-hexahydroquinoline: an attractive scaffold with diverse biological activitiesSara Ranjbar, Najmeh Edraki, Omidreza Firuzi, et al.Mediators of Inflammation|August 2, 2021
Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen PlanusMaryam Mardani, Hossein Mofidi, Ladan Dastgheib, et al.Dermatologic Therapy|September 2, 2022
Montelukast as an effective adjuvant in the treatment of moderate acne vulgarisNegin Fazelzadeh Haghighi, Ladan Dastgheib, Nasrin Saki, et al.Toxicology Research|September 26, 2024
A toxicogenomics-based identification of potential mechanisms and signaling pathways involved in PFCs-induced cancer in humanZahra Dehghani, Sara Ranjbar, Farbod Shahabinezhad, et al.Dermatology Practical & Conceptual|May 26, 2026
Efficacy of Oral Cicaglocal for Wound Healing and Pruritus Alleviation in Patients with Epidermolysis Bullosa: A Single-Arm Clinical TrialMohammad Mahdi Parvizi, Sara Nayebi, Mohammad Kamali, et al.Research in Pharmaceutical Sciences|February 2, 2018
Design, synthesis, cytotoxicity evaluation and docking studies of 1,2,4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitorsSara Ranjbar, Najmeh Edraki, Mahsima Khoshneviszadeh, et al.Molecular Diversity|October 21, 2021
5-Oxo-hexahydroquinoline and 5-oxo-tetrahydrocyclopentapyridine derivatives as promising antiproliferative agents with potential apoptosis-inducing capacitySara Ranjbar, Mehdi Khoshneviszadeh, Marjan Tavakkoli, et al.Scientific Reports|November 28, 2025
Safety and efficacy of niosomal and conventional tranexamic acid/niacinamide vs. hydroquinone creams in melasma: A randomized, double-blind, case-controlled clinical trialParisa Ghasemiyeh, Negin Fazelzadeh Haghighi, Ladan Dastgheib, et al.Pageof 5